New Leaf Pharmaceuticals

New Leaf Pharmaceuticals was a private Connecticut-based health and wellness company focused on differentiated over-the-counter and consumer-oriented nasal spray products. Its principal marketed product was Rhinodol, a CBD-containing intranasal spray promoted for rapid absorption and positioned around headache, inflammation, and related wellness use cases. The company described itself as established in 2005 and affiliated its formulation experience with Sinol USA, emphasizing nasal spray development and commercialization rather than a traditional clinical-stage biotech pipeline. Public evidence indicates the legal entity New Leaf Pharmaceuticals, LLC later became forfeited/dissolved in Connecticut, so the company appears inactive as a corporate entity even though legacy web pages remain online. It is better characterized as a specialty OTC/wellness pharmaceutical marketer than as a drug-development biotech company.